Recursion Pharmaceuticals
Robin McDougall is a seasoned professional in the field of translational modeling and pharmacology, currently serving as Senior Director of Translational Modeling at Recursion since June 2023. Prior experience includes a role as Director of Clinical Pharmacology and Toxicology at Repare Therapeutics from October 2021 to June 2023, and various positions at Alnylam Pharmaceuticals, AstraZeneca, AEgis Technologies, SIMeng Inc., and CAE, with a focus on modeling and drug safety. Robin holds a Bachelor of Engineering in Mechanical Engineering from McGill University and advanced degrees, including a Master of Applied Science and a Ph.D. in Engineering and Applied Science from Ontario Tech University.
This person is not in any teams
This person is not in any offices